Clinical Trial Update: Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating abatacept for adults with Takayasu arteritis and giant cell arteritis completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Takayasu Arteritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Takayasu's Arteritis, Giant Cell Arteritis | Phase 2 | Status: COMPLETED | Results posted: 2018-02-26